Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...

The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

Trump Tariffs have grabbed headlines and become the topic of discussion around the world. Now there is a reality-check on the food ingredie...

The oral drug, pociredir, was being tested ⁠to treat sickle-cell ⁠disease, an inherited blood disorder that can trigger pain, anemia and or...

Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Wockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...

The U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...

Tata Elxsi’s AnaTel reflects the growing shift toward AI-native healthcare software engineering, bringing AI-driven automation into regulat...

What is mifepristone, and why is it used? A federal appeals court has restricted access to mifepristone by blocking mailing of prescription...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

India and New Zealand will sign a Free Trade Agreement on Monday, April 27. This landmark deal aims to boost bilateral trade significantly....

Cannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.

The company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ingredients market, de...

Amid growing scrutiny from the U.S. FDA over documentation practices and contamination issues, Granules India is reinforcing its manufactur...

A spokesperson from UK drug regulator told ET that the agency is in touch with the US FDA to assess how this ban would affect Ranbaxy drugs...